Displaying 1 - 12 of 39

Display:

12 24 48

Metabolism, Alcohol & Toxicity

5

International Medical Press: Obesity management in NAFLD/NASH: can we do more? - Digital ILC 2020

View

Metabolism, Alcohol & Toxicity

5

International Medical Press: Obesity management in NAFLD/NASH: can we do more? - Digital ILC 2020

View

Metabolism, Alcohol & Toxicity

5

International Medical Press: Obesity management in NAFLD/NASH: can we do more? - Digital ILC 2020

View

Metabolism, Alcohol & Toxicity

5

International Medical Press: Obesity management in NAFLD/NASH: can we do more? - Digital ILC 2020

View

Metabolism, Alcohol & Toxicity

5

International Medical Press: Obesity management in NAFLD/NASH: can we do more? - Digital ILC 2020

View

Metabolism, Alcohol & Toxicity

5

Novo Nordisk:  NASH – the metabolic disease of the liver - Digital ILC 2020

View

Metabolism, Alcohol & Toxicity

5

Novo Nordisk:  NASH – the metabolic disease of the liver - Digital ILC 2020

View

Metabolism, Alcohol & Toxicity

5

Novo Nordisk:  NASH – the metabolic disease of the liver - Digital ILC 2020

View

Metabolism, Alcohol & Toxicity

5

Novo Nordisk:  NASH – the metabolic disease of the liver - Digital ILC 2020

View

Metabolism, Alcohol & Toxicity

5

Novo Nordisk:  NASH – the metabolic disease of the liver - Digital ILC 2020

View

Liver Tumours

5

Bristol-Myers Squibb: Evolving Treatment Landscape of HCC - Digital ILC 2020

View

Liver Tumours

5

Bristol-Myers Squibb: Evolving Treatment Landscape of HCC - Digital ILC 2020

View

Displaying 1 - 12 of 39

Display:

12 24 48